| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-02-14 | Mr. Mark MosslerCAO | 6.15k | 0.00 | Derivative Exercise and Retained Stock | - | 5.79k | -1,704.16% |
| 2026-02-14 | Mr. Mark MosslerCAO | -3.27k | 6.18k | Derivative Exercise and Sale | 1.89 | 5.79k | - |
| 2026-02-14 | Dr. Leonard M. J. ReynoChief Medical Officer | 14.37k | 0.00 | Derivative Exercise and Retained Stock | - | 25.48k | 129.39% |
| 2026-02-14 | Dr. Leonard M. J. ReynoChief Medical Officer | -16.58k | 31.33k | Derivative Exercise and Sale | 1.89 | 25.48k | - |
| 2026-02-13 | Mr. Scott N. BoyleChief Business Officer | 16.95k | 0.00 | Derivative Exercise and Retained Stock | - | 37.78k | 81.35% |
| 2026-02-13 | Mr. Scott N. BoyleChief Business Officer | -9.00k | 17.02k | Derivative Exercise and Sale | 1.89 | 37.78k | - |
| 2026-02-13 | Ms. Kelly A. SchickCPO | 16.95k | 0.00 | Derivative Exercise and Retained Stock | - | 38.86k | 77.34% |
| 2026-02-13 | Ms. Kelly A. SchickCPO | -9.00k | 17.02k | Derivative Exercise and Sale | 1.89 | 38.86k | - |
| 2026-02-14 | Ms. Paige MahaneyChief Scientific Officer | 4.60k | 0.00 | Derivative Exercise and Retained Stock | - | 18.16k | 33.96% |
| 2026-02-14 | Ms. Paige MahaneyChief Scientific Officer | -2.45k | 4.62k | Derivative Exercise and Sale | 1.89 | 18.16k | - |
| 2026-02-14 | Mr. Andrew J. HirschCEO, President & Director | 53.91k | 0.00 | Derivative Exercise and Retained Stock | - | 135.21k | 66.32% |
| 2026-02-14 | Mr. Andrew J. HirschCEO, President & Director | -48.21k | 91.12k | Derivative Exercise and Sale | 1.89 | 135.21k | - |
| 2026-02-13 | Ms. Kendra R. AdamsCFO and Head of Corporate Affairs & Treasurer | 17.46k | 0.00 | Derivative Exercise and Retained Stock | - | 45.17k | 62.98% |
| 2026-02-13 | Ms. Kendra R. AdamsCFO and Head of Corporate Affairs & Treasurer | -17.24k | 32.59k | Derivative Exercise and Sale | 1.89 | 45.17k | - |
| 2026-01-16 | Dr. Leonard M. J. ReynoChief Medical Officer | -10.00k | 22.20k | 売り | 2.22 | 11.11k | -47.38% |
| 2025-10-28 | Ms. Paige MahaneyChief Scientific Officer | 13.56k | 0.00 | Derivative Exercise and Retained Stock | - | 13.56k | - |
| 2025-10-28 | Ms. Paige MahaneyChief Scientific Officer | -5.64k | 14.56k | Derivative Exercise and Sale | 2.58 | 13.56k | - |
| 2025-09-18 | Ms. Kendra R. AdamsCFO and Head of Corporate Affairs & Treasurer | 3.48k | 0.00 | Derivative Exercise and Retained Stock | - | 27.72k | 14.33% |
| 2025-09-18 | Ms. Kendra R. AdamsCFO and Head of Corporate Affairs & Treasurer | -2.78k | 9.21k | Derivative Exercise and Sale | 3.32 | 27.72k | - |
| 2025-07-10 | Dr. Leonard M. J. ReynoChief Medical Officer | 7.94k | 0.00 | Derivative Exercise and Retained Stock | - | 21.11k | 60.34% |
| 2025-07-10 | Dr. Leonard M. J. ReynoChief Medical Officer | -7.38k | 14.69k | Derivative Exercise and Sale | 1.99 | 21.11k | - |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。